Genome-wide studies highlighted the effect in Crohn's disease (CD) and ulcerative colitis (UC) susceptibility of single nucleotide polymorphisms (SNPs) in 3p21, where BSN (bassoon), MST1 (macrophage stimulating-1) and MST1R (MST1 Receptor) genes map. MST1R expression was significantly downregulated in multiple sclerosis (MS) compared with control brains, resembling findings in the MS mouse model. We pursued to replicate the effect of this locus on inflammatory bowel diseases and to evaluate its contribution to MS risk. Polymorphisms rs9858542, rs2131109 and rs1128535 were analysed by TaqMan assays in Spanish patients (370 CD, 405 UC and 415 MS) and 800 ethnically matched controls. Allele frequencies of these SNPs were significantly different in CD patients compared with controls [rs9858542: P ¼ 0.001, Odds ratio (OR) ¼ 1.35; rs2131109: P ¼ 0.0005, OR ¼ 1.37; rs1128535: P ¼ 0.007, OR ¼ 0.78] and, specifically, in the ileal phenotype [rs9858542: P ¼ 0.0004, OR ¼ 1.47; rs2131109: P ¼ 0.00009, OR ¼ 1.52; rs1128535: P ¼ 0.02, OR ¼ 0.69]. No differences were detected between UC or MS patients and control individuals. The effect of this locus on CD predisposition was replicated, but no influence on UC or MS predisposition could be detected. This susceptibility locus seems to affect mainly to the ileal CD subphenotype, although this point awaits further corroboration in independent cohorts.
Introduction
The search for susceptibility variants in common diseases has witnessed a surge in the identification of new risk loci through genome-wide association studies (GWAS). Provided a successful replication is achieved, further insight in the etiology of multifactorial diseases will come from the assessment of how the associated polymorphisms affect the different clinical subgroups. One of these loci related with Crohn's disease (CD) susceptibility maps to the 3p21 region, where the BSN (bassoon) and MST1 (macrophage stimulating 1) genes are located. 1, 2 Recently, the association of polymorphisms in this chromosomal region with ulcerative colitis (UC) has been also reported, [3] [4] [5] although replication was not achieved in every GWAS performed in UC. 6 The macrophage stimulating protein is a soluble cytokine that was originally identified by its stimulatory activities on mouse resident macrophages. 7 Through binding to its receptor, encoded by the MST1R gene, it stimulates dissociation of epithelia and works as an inflammation modulator by repressing the production of nitric oxide and IL-12. 8, 9 This multifunctional factor regulates cell adhesion and motility, growth and survival. Moreover, the MST1R-deficient mouse showed a more rapid onset after EAE (experimental autoimmune encephalitis) induction with overall worsened severity, together with exacerbated demyelization, axonal injury and neuroinflammation. 10 Genetic risk factors are sometimes shared by multiple diseases (the PTPN22 C1858T allele or the STAT4 gene 11, 12 ). Imputation from the Wellcome Trust Case Control Consortium data 1 allows discarding a similar role of the BSN polymorphism rs9858542 originally found associated with CD in other autoimmune complex diseases, like rheumatoid arthritis or type I diabetes. The BSN gene encodes a vertebrate-specific protein with essential functions at central nervous system synapses, regulating neurotransmitter release. In mutant mice, loss of BSN protein causes reduction in normal synaptic transmission attributed to the inactivation of glutamatergic synapses. 13, 14 Even though genome-wide studies on multiple sclerosis (MS) susceptibility 15, 16 did not highlight the association with this locus, either the stringent threshold for correction imposed in this kind of hypothesis-free scans or a poor coverage of the specific chromosomal region may hamper the localization of risk factors on a first hit level. Our aim with this work was to analyse the effect of this locus in the different clinical subphenotypes of inflammatory bowel diseases and to extend the study to another immune-related condition in which a putative functional involvement of the tested genes could be anticipated, as MS. For doing so, the frequencies of the BSN polymorphism originally found associated with CD, rs9858542, and of another variant in the gene selected to aid in the study of haplotypes, rs2131109, were analysed in our collections of CD, UC and MS Spanish patients and compared with ethnically matched healthy controls. Additionally, a putative independent signal tagged by rs1128535 17 was also studied in our population. This single nucleotide polymorphism (SNP) is located in the TRAIP gene, encoding the TRAF-interacting protein, which was initially identified as an NF-kB inhibitor. 18 Two proxies of this polymorphism are amino acid changing variants of the MST1R gene and therefore could have potential functional implications on these diseases.
Materials and methods
Seven hundred and seventy-five Spanish IBD (370 CD and 405 UC) patients, 415 MS patients and 800 ethnically matched controls, mostly blood donors and staff, were consecutively recruited from the Hospital Clínico (Madrid) and included in the study after informed consent. The Ethics Committee of the Hospital Clínico San Carlos approved the study.
Diagnosis of IBD patients was based on standard clinical, radiologic, endoscopic and histologic criteria. 19 The mean age at onset for UC patients was 38 years; 41% of them suffered pancolitis, 47% extraintestinal manifestations and 13% colectomy. CD patients were classified according to the location of the lesions in ileal (L1, 48%), colonic (L2, 16%), ileocolonic (L3, 32%) and upper gastrointestinal tract (L4, 3%) and according to the disease behaviour in inflammatory (B1, 43%), stricturing (B2, 15%) and perforating (B3, 42%). Only 20% of the CD patients debuted after the age of 40.
MS patients were diagnosed based on the Poser criteria 20 and 36% of patients carried the HLA DRB1*1501 allele. Most patients were relapsing remitting (79%), 11% secondary progressive and 9% primary progressive. Their mean age at MS onset was 29 ± 9 years.
Genotyping of the samples was carried out with TaqMan Assays from Applied Biosystems [C___3134319_10 and C___3158330_10 corresponding to rs9858542 and rs2131109, and rs2271961 with r 2 ¼ 1 with rs1128535] using 384-well plates in a 7900HT Fast Real-Time PCR system, under the conditions recommended by the manufacturer (Applied Biosystems, Foster City, CA, USA). Genotyping call-rate success was over 96% for the three SNPs and all patient groups and controls.
The statistical analysis to compare allelic and genotypic distributions was performed using w 2 test or Fisher's exact test included in a standard statistical package (Epi Info vs 6.02; World Health Organization, Geneva, Switzerland). Odds ratios (ORs) were calculated, and their 95% confidence intervals were estimated using the Cornfield method. Linkage disequilibrium was measured by calculating two parameters, r 2 and D'.
Results
The three studied polymorphisms, rs9858542, rs2131109 and rs1128535 conformed to Hardy-Weinberg equilibrium in the control samples and genotype and allele frequencies observed in CD, UC and MS patients and healthy individuals are summarized in Table 1 . As shown, significant differences were observed between CD patients and controls in the allelic frequencies (Table 1) (Table 2) , again a significant difference could be detected between ileal and colonic CD patients carriers of the minor allele for the two first SNPs (P ¼ 0.04 and P ¼ 0.001 for rs9858542 and rs2131109, respectively; see Table 2 ). Compared with healthy controls, the minor allele frequencies at both polymorphisms were significantly elevated in ileal CD patients Table 2 ]. As the NOD2/ CARD15-positive group is enriched for the CD ileal phenotype, 21 this would seem an expected result. In fact, when ileal CD patients were stratified by NOD2/CARD15 status, no significant difference in allelic frequencies was observed between NOD2/CARD15-positive and NOD2/ CARD15-negative groups (P ¼ 0.18); although a stronger signal arose from the NOD2/CARD15-positive comparison with controls [OR (95% CI) ¼ 1.78 (1.27-2.5) vs OR (95% CI) ¼ 1.36 (1.04-1.77)].
The analysis of the haplotypes conformed by these three polymorphisms evidenced two of them conferring susceptibility and protection towards CD (Table 4 ). The risk haplotype was tagged by rs9858542, but none of the studied SNPs effectively tagged the protective one.
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Discussion
The polymorphism originally associated with CD, rs9858542, is a synonymous coding SNP within the BSN gene. 1 A polymorphism quasi equivalent to this one from a genetic standpoint (rs3197999; r 2 ¼ 0.95) results in an amino acid change R689C in the MST1 gene, which suggests its putative etiological role. Therefore, some functional studies are warranted to ascertain whether the latter or some other polymorphism in tight linkage disequilibrium with it is the causal responsible for the association found.
The present data evidence a significant association of rs9858542 with CD, but not with UC or MS risk, and a similar pattern was found with other variants with partial genetic equivalence with the former (r 2 ¼ 0.4 with either rs2131109 or rs1128535). The design of our study seems sufficiently powered (over 80%) to detect the expected OR ¼ 1.31 previously described for UC or CD. 4 However, in our population, the effect of this locus seems to be exclusive for CD, and more specifically, for ileal CD.
Replication of association results is essential to establish the validity of the initial findings. Lack of replication can be indicative of a substantial difference between the studied cohorts. The basis for the discrepancy found up to date in the association results with UC is not obvious. Fisher et al., 3 Franke et al. 4 and Goyette et al. 5 showed 
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17 studied rs1128535 and no association was seen for UC, either. No bias for a clinical subphenotype could be detected between UC patients (Table 3) , although in this case the statistical power is lower. Hopefully our work will encourage further analyses to ascertain the precise role of this locus on IBD phenotypes. Genuine differences can also arise from the differential linkage disequilibrium of the identified genetic marker with the true functional gene variant in different populations. Given inter-ethnic differences in patterns of linkage disequilibrium, we aimed at testing not only the initially described associated polymorphism, but also other variants with limited genetic equivalence. Interestingly, in our population, rs2131109 shows an OR ¼ 0.99 for UC with only borderline overlapping of the 95% confidence intervals between UC and CD (Table 1) . Complementary efforts in multiple ethnicities and exploration of variations around strong signals of association should help to address this issue. Moreover, the joint effects of genes and environment should not be forgotten as a putative source of heterogeneity. The robustness of the study does not guarantee the consistency of the proposed association, a good example comes from the association of the FTO (fat mass and obesity associated) gene with type II diabetes first described in a genome-wide scan 1 and subsequently replicated in some, 22 but not in other studies. [23] [24] [25] The explanation of the divergent data was the underlying confounding effect of obesity that, once controlled, abolished the case-control differences originally reported for type II diabetes. In our case, two GWAS 3, 6 yielded different results in terms of the association with UC. The identification of the source of heterogeneity related with case ascertainment, environmental factors, gene-gene interactions or the impact of a covariate will contribute to the better knowledge of the mechanism of action as, at the end, is the confirmation in independent cohorts which confers the overall strength to the association.
The observed risk and protection haplotypes (Table 4 ) not necessarily mean independent effects in the locus, as a putative causal SNP could explain both through linkage disequilibrium of one allele with haplotypes I and III and of the other allele with haplotypes II and IV.
MS is an autoimmune demyelinating disease with inflammatory and neurodegenerative components influencing its pathogenesis, although disease aetiology is not completely understood. The identification of novel susceptibility genes will aid in the elucidation of the molecular basis of this complex neurological disorder. Our results did not evidence the involvement of polymorphisms within this locus in MS predisposition, even though the mRNA and protein abundance in the central nervous system of the macrophage stimulating protein receptor were diminished in both MS patients and the MS animal model. 10 In summary, the original effect on CD susceptibility provided by rs9858542 (or its proxy, rs3197999) was successfully replicated in an independent population. Further, a specific effect warranting corroboration was ascribed to the ileal form of CD, which shows a significant difference with both colonic CD and UC. No significant difference with healthy controls could be detected for these polymorphisms in UC or MS Spanish patients. 
